Sight Diagnostics raised €24M in a Series C round in Jan 2019. The company is based in Tel Aviv, Israel. Investors in the round: GO CAPITAL, Jack Nicklaus II, Longliv Ventures and 2 others. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
